Ireland
--:--IST
Recruiting Not applicable

Intermittent Ephedrine Boluses for Prophylaxis Against Postinduction Hypotension

NCT07722013 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-08-04
Last updated
2026-08-06

Condition(s) studied

Postinduction Hypotension

Investigational drug(s) / intervention(s)

Normal SalineEphedrine →

Normal Saline: four 10-mL syringes of normal saline, The patient will receive the first dose of the intervention with induction (0.1 ml/kg). After induction of anesthesia, the study drug will be given every 5 min for 20 min and will be withheld if MAP was ≥80 mmHg or if any vasopressor is given within 2 min of the current scheduled dose

Ephedrine: four 10-mL syringes of ephedrine 1 mg/mL. The patient will receive the first dose of the intervention with induction (0.1 ml/kg). After induction of anesthesia, the study drug will be given every 5 min for 20 min and will be withheld if MAP was ≥80 mmHg or if any vasopressor is given within 2 min of the current scheduled dose.

Study summary

The aim of this work is to assess the efficacy of intermittent ephedrine boluses in prophylaxis against postinduction hypotension in high-risk patients undergoing major abdominal surgery, compared to standard care.

Eligibility

Sex
ALL
Min age
50 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult patients aged \>50 years, * weight \>50 kg, * American Society of Anesthesiologists (ASA) Physical Status score of \> I, * undergoing major abdominal surgery Exclusion Criteria: * Severe cardiac morbidities (impaired contractility with ejection fraction \< 40%, heart block, significant uncontrolled arrhythmias, tight stenotic valvular lesions) * Acute cardiovascular pathologies: acute/decompensated heart failure, acute coronary syndrome * Uncontrolled hypertension (systolic blood pressure\>150 mmHg) * Preoperative HR more than 110 bpm despite proper fluid management and patients with renal impairment * Renal impairment * Patients on vasopressor infusion, * Allergy of any of the study drugs

Primary outcome measure(s)

  • incidence of postinduction hypotension — from induction of anesthesia until 20 minutes after induction
    mean arterial pressure \< 65 mmHg

Trial sites (1)

FacilityCityRegionStatus
Kasr Alainy Hospital Cairo Egypt Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07722013 on ClinicalTrials.gov ↗ ← All trials in Egypt